CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Cash flows from operating activities:
Net (loss) earnings	$ (9,184)	$ 9,851
Adjustments to reconcile net (loss) earnings to net cash provided by operating activities:
Stock-based compensation expense	25,575	19,282
Amortization of intangibles	12,980	14,539
Bad debt expense	17,807	14,310
Depreciation	12,138	6,999
Deferred income taxes	(8,348)	(14,377)
Other adjustments, net	3,216	1,352
Changes in assets and liabilities, net of effects of acquisitions and dispositions:
Accounts receivable	(21,226)	(39,729)
Other assets	3,043	1,159
Accounts payable and other liabilities	21,008	11,856
Income taxes payable and receivable	(873)	146
Deferred revenue	(230)	1,314
Net cash provided by operating activities	55,906	26,702
Cash flows from investing activities:
Acquisition, net of cash acquired	0	(20,341)
Capital expenditures	(13,236)	(15,177)
Proceeds from maturities of marketable debt securities		25,000
Net proceeds from the sale of a business	767	23,655
Other, net		(103)
Net cash (used in) provided by investing activities	(12,469)	13,034
Cash flows from financing activities:
Principal payments on term loan	(3,438)	(3,438)
Principal payments on related party debt	0	(1,008)
Purchase of treasury stock	(38,512)	0
Proceeds from the exercise of stock options	0	573
Withholding taxes paid on behalf of employees on net settled stock-based awards	(3,222)	(16,544)
Distribution to IAC pursuant to the tax sharing agreement	0	(11,355)
Purchase of noncontrolling interests	(3,165)	0
Net cash used in financing activities	(48,337)	(31,772)
Total cash (used) provided	(4,900)	7,964
Effect of exchange rate changes on cash and cash equivalents and restricted cash	(1,327)	401
Net (decrease) increase in cash and cash equivalents and restricted cash	(6,227)	8,365
Cash and cash equivalents and restricted cash at beginning of period	391,478	338,821
Cash and cash equivalents and restricted cash at end of period	$ 385,251	$ 347,186